Weekly Briefing

Briefing for the week of October 20 – October 26, 2026

Coverage period: October 20, 2026 – October 26, 2026

Published October 26, 2026

Litigation and implementation drove the week as ACA and Medicare open enrollment began. A second trade group sued over CMS's freeze on new ACA agents and brokers ahead of the Nov. 1 start of 2027 enrollment, and hospitals and drugmakers kept fighting over the revived 340B rebate pilot slated for Jan. 1, 2027. CMS and the Labor Department announced a voluntary employer statement on electronic prior authorization. Insurers disclosed 2027 ACA footprints with new counties for some and exits by others, and a JAMA Health Forum study found that mental health provider directories often fail patients. Kaiser-backed Risant Health agreed to acquire Oklahoma's Integris Health, subject to regulatory approval.

This Week

The Developments

Litigation

Second lawsuit challenges CMS's freeze on new ACA agents and brokers ahead of 2027 open enrollment

Interim final rule published Sept 23, 2026 (effective Sept 22); suits reported about Oct 16 and Oct 21; open enrollment starts Nov 1

What changed

HHS and CMS issued an interim final rule (CMS-9872-IFC, 91 Fed. Reg. 60317, Sept. 23, 2026) that pauses registration of agents and brokers who lack a current 2026 agreement to help consumers enroll through the federally facilitated marketplaces for plan year 2027. It does not cover state-based exchanges or web brokers, runs through Feb. 1, 2027 unless CMS changes it, and takes comments through Nov. 21. The rule cites over 624,000 consumer complaints from 2023 through 2025 alleging unauthorized enrollments or plan switches, and says CMS canceled about 315,000 plan-year 2026 policies covering more than 760,000 people on Aug. 31. Healthcare Dive reports that the National Association of Benefits and Insurance Professionals sued in the District of Maryland around Oct. 16, and that Health Agents for America filed a second suit around Oct. 21, arguing the rule violates the Administrative Procedure Act and exceeds CMS's authority. Both seek to halt the freeze before open enrollment. The NAIC, which represents state insurance regulators, wrote to CMS warning the freeze could reduce consumers' access to help.

Why it matters

Brokers and agents help many people choose and enroll in marketplace plans, and 2027 enrollment follows insurer exits and double-digit proposed premium increases. The freeze weighs an anti-fraud rationale against reduced enrollment assistance. The fraud and cancellation figures are CMS's own claims in the rule; the plaintiffs' arguments are allegations, and no court ruling has been reported. Suit dates are approximate and come from trade press.

  • Access
  • Accountability
Warrants deeper follow-up. Check the Maryland dockets for any injunction ruling before Nov. 1.

Sources

Background from our research

Storylines

Litigation

Hospitals and drugmakers clash in court over the revived 340B rebate pilot

Hospital suit filed Oct 9, 2026; drugmaker motions Oct 14; opposition filed Oct 21; pilot scheduled to start Jan 1, 2027

What changed

The American Hospital Association, the Maine Hospital Association and four safety-net hospitals sued in the U.S. District Court for the District of Maine on Oct. 9 to stop the administration's revised 340B rebate model, which is scheduled to take effect Jan. 1, 2027. Under a rebate model, covered hospitals buy certain drugs at full price and later claim a rebate rather than receiving the discount at purchase. Per Healthcare Dive, AbbVie, Bristol-Myers Squibb and Boehringer Ingelheim moved to intervene on Oct. 14, and PhRMA filed separately. On Oct. 21 the AHA and co-plaintiffs asked the court to deny intervention, noting that a court rejected similar requests in the earlier case over the first version of the pilot. The plaintiffs say the program would impose over $1 billion a year in administrative costs on hospitals.

Why it matters

340B is meant to help safety-net providers stretch limited resources, and the dispute is about who bears cash-flow and administrative burden. Drugmakers argue rebates would curb duplicate discounts; hospitals argue the model threatens safety-net finances. The $1 billion estimate is the plaintiffs' own and is not independently verified. No ruling has been reported.

  • Affordability
  • Access
  • Accountability
Warrants deeper follow-up. Watch for a ruling on intervention and any preliminary-injunction schedule ahead of the Jan. 1, 2027 start.

Sources

Background from our research

Storylines

Announced

CMS and Labor Department announce five large employers' support for electronic prior authorization in self-funded plans

Announced Oct 21, 2026; related payer API requirement takes effect Jan 1, 2027

What changed

CMS announced that Amazon, Axon Enterprise, Google, Meta and Oracle signed a statement of support for making the electronic prior authorization capabilities developed under the 2025 insurer pledge available to employers that sponsor self-funded health plans. The release sets no deadlines, lists no specific required actions and describes no enforcement mechanism. Healthcare Dive reports that nearly 60 health plans signed the 2025 voluntary pledge and say they have cut prior authorizations by 11%, a figure the plans themselves reported, and that some providers say they have seen no improvement. The release separately refers to a rule requiring certain payers to implement electronic prior authorization beginning Jan. 1, 2027.

Why it matters

Self-funded employer plans, governed by ERISA, were outside many earlier prior authorization reforms, so employer commitments could extend the reach of the effort, but this is a voluntary statement, not a requirement. The effect on denials, delays or patient outcomes is not measured in the announcement, and the 11% reduction is self-reported by insurers.

  • Access
  • Accountability

Sources

Background from our research

Storylines

Announced

Insurers detail 2027 ACA footprints: new counties for some, exits by others

Insurer announcements about Oct 20, 2026; open enrollment starts Nov 1

What changed

Fierce Healthcare reports that Centene (Ambetter) will expand into 55 more counties for 2027 and Oscar Health will offer plans in 713 counties across 21 states, a 24% increase in counties served. Becker's Payer Issues adds that Centene is ending exchange coverage in Delaware and New Hampshire, Oscar is entering South Carolina, and UnitedHealthcare is leaving Georgia's marketplace while expanding service areas in five other states. Cigna is pulling back from exchange coverage affecting about 369,000 members, Molina is cutting more than half of its marketplace states, and Baylor Scott & White Health Plan, ConnectiCare and Providence Health Plan are leaving exchanges entirely. Separately, healthinsurance.org's 2027 open-enrollment guide reports a median proposed rate increase of about 15%, a 2027 out-of-pocket maximum of $12,000, and a Nov. 1 start to open enrollment in most states.

Why it matters

Insurer participation shapes the choices and prices marketplace enrollees see, and exits force people to pick a new plan rather than auto-renew. These are insurers' own disclosures as relayed by trade press, and proposed rate increases are proposals, not final approved rates. Net effects on choice by county and on premiums actually paid after subsidies are not established by these sources.

  • Access
  • Affordability
Warrants deeper follow-up. Compare against KFF's insurer-participation tracker and CMS's county-level data once open enrollment plan data are posted.

Sources

Background from our research

Storylines

Report

JAMA Health Forum study: few calls to listed mental health clinicians in commercial networks produce an appointment

Published Oct 16, 2026; reported Oct 21; calls placed Oct 2025 – Mar 2026

What changed

Researchers from Ohio State University and Stanford placed 5,822 secret-shopper calls to psychiatrists and psychologists listed in the largest commercial carrier's online directory in each of five states (Delaware, Montana, New Jersey, Rhode Island and Virginia) between October 2025 and March 2026. Of the 38.7% of calls that could be evaluated, 23.6% led to an appointment with the listed clinician (32.1% counting alternate clinicians at the same number). Directory inaccuracies appeared in 55.6% of evaluable calls, most often wrong contact information (31.0%) and specialty errors (22.2%). Another 21.6% were blocked by clinicians not accepting new patients or not offering appointments. Mean wait for an appointment was 20.5 days. The authors conclude that commercial coverage did not translate into ready access to mental health care. (The article was published a few days before this briefing's window and reported within it.)

Why it matters

It provides measured evidence on the gap between having insurance and getting care, specifically for mental health, and it bears on the directory-accuracy provisions CMS has proposed for Medicare Advantage. Caveats: one large carrier in each of five states, most calls could not be evaluated (mostly unanswered), and results may not generalize nationally or to other insurers.

  • Access
  • Quality

Sources

Background from our research

Storylines

Announced

Kaiser-backed Risant Health agrees to acquire Oklahoma's Integris Health

Announced Oct 21, 2026; pending regulatory approvals

What changed

Risant Health, the nonprofit launched by Kaiser Permanente, and Oklahoma City-based Integris Health announced a definitive agreement for Integris to join Risant, pending regulatory approvals. Per Becker's Hospital Review, no deal terms or expected closing date were disclosed. Integris would keep its name, brand, medical staff and leadership team and continue working with other health plans and independent physicians. It would be Risant's third system after Geisinger and Cone Health, and operates 10 acute and 10 specialty hospitals with about 13,000 employees.

Why it matters

The deal adds to multi-state nonprofit system consolidation at a time when systems face pressure from federal funding changes. Risant frames the model around value-based care and keeping systems' local identity; the announcement does not show whether it changes prices, access or quality. Performance figures cited for Risant's existing partners come from the companies' own release. This is an announced agreement, not a completed transaction.

  • Access
  • Affordability
  • Reform
Warrants deeper follow-up. Watch for regulatory review, Oklahoma attorney general or charity-asset scrutiny, and eventual price or service changes at Geisinger and Cone as comparison cases.

Sources

Background from our research

Storylines

Prioritized Follow-Up

  1. ACA broker freeze litigation (D. Md.): watch for a ruling on injunction requests before Nov. 1 open enrollment; two suits are now pending, and comments on the rule are due Nov. 21.
  2. 340B rebate pilot (D. Me.): watch whether the court allows drugmaker intervention and whether the Jan. 1, 2027 start holds.
  3. Risant–Integris: watch for terms, regulatory review and any state or federal antitrust or charity-asset scrutiny.

← All Weekly Briefings